SORRENTO THERAPEUTIC Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Week In Review: Sorrento Therapeutics Fights $933 Million Take-Private Bid
Article By: ChinaBio® Today
Saturday, February 1, 2020 5:24 PM EST
Sorrento Therapeutics, a San Diego-Nanjing-Suzhou biopharma, rejected a $7 per share take-private offer from an unnamed PE company that valued the company at $933 million. Sorrento reported a loss of $57 million over the last 12 months.
In this article: AZN, ROG, SRNE, DMPI, EYPT
Read
Sorrento Rejects Takeover Offer
Article By: Benzinga
Monday, January 27, 2020 9:51 AM EST
Sorrento Therapeutics, Inc. announced on Monday, after reviewing the latest acquisition proposal in consultation with its advisors, is rejecting a takeover bid.
In this article: SRNE
Read
Stock Charts To Watch - Wednesday, Jan. 15
Video By: Harry Boxer
Wednesday, January 15, 2020 11:12 PM EST
Applied Optoelectronics, Inc. had a wonderful swing back in 2016-2017, then spent the last couple of years in an ugly pattern.
In this video: CGC, IMGN, LLNW, AAOI, KERN, SRNE
Watch
5 Extremely Lucrative Biotechs To Track Now
Article By: TipRanks
Wednesday, September 12, 2018 3:22 PM EST
September is typically an ugly month for stocks. Biotech stocks march to a different tune. They can spike massively on positive news — be it key trial results or regulatory approvals.
In this article: SRNE, GLMD, TOCA, SBPH, OBSV
Read
Week In Review: C-Bridge Raising Another $650 Million For China Healthcare
Article By: ChinaBio® Today
Saturday, February 3, 2018 4:43 PM EST
Shanghai's C-Bridge Capital is raising capital for its third healthcare private equity fund with a target of $650 million (see story). Just six months ago, C-Bridge closed its second PE fund at a hard cap of $400 million.
In this article: CASI, SRNE, PBYI
Read

PARTNER HEADLINES

Latest Tweets for $SRNE

No tweets yet!